PELL Bio-Med Technology Co Ltd (6949) Stock Statistics & Valuation Metrics

PELL Bio-Med Technology Co Ltd has a market cap or net worth of TWD 49.23B. The enterprise value is TWD 55.09B.

Market Cap

TWD 49.23B

Enterprise Value

TWD 55.09B

PELL Bio-Med Technology Co Ltd has 1,311,601,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,311,601,000

Owned by Insiders

―

Owned by Institutions

1.04%

PELL Bio-Med Technology Co Ltd’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -24.20%.

Return on Equity (ROE)

-0.30

Return on Assets (ROA)

-0.20

Return on Invested Capital (ROIC)

-24.20%

Return on Capital Employed (ROCE)

-0.26

Revenue Per Employee

334.30K

Profits Per Employee

-4.51M

Employee Count

94

Asset Turnover

0.01

Inventory Turnover

5.41

The current PE Ratio of PELL Bio-Med Technology Co Ltd is -112.36. PELL Bio-Med Technology Co Ltd’s PEG ratio is 7.27.

PE Ratio

-112.36

PS Ratio

1812.78

PB Ratio

20.35

Price to FCF

-83.49

Price to Operating Cash Flow

-130.89

PEG Ratio

7.27

In the last 12 months, PELL Bio-Med Technology Co Ltd had revenue of 31.42M and earned -423.94M in profits. Earnings per share was -0.36.

Revenue

31.42M

Gross Profit

-4.39M

Operating Income

-467.35M

Pretax Income

-452.67M

Net Income

-423.94M

EBITDA

-420.23M

Earnings Per Share (EPS)

-0.36

In the last 12 months, operating cash flow was -399.90M and capital expenditures -228.17M, giving a free cash flow of -628.07M billion.

Operating Cash Flow

-399.90M

Free Cash Flow

-628.07M

Free Cash Flow per Share

-0.48

PELL Bio-Med Technology Co Ltd pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-1.28%

Earnings Yield

-0.92%

Beta

0.95

52-Week Price Change

103.61%

50-Day Moving Average

―

200-Day Moving Average

―

Relative Strength Index (RSI)

36.83

Average Volume (3m)

6.83M

PELL Bio-Med Technology Co Ltd upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 05, 2026

Next Earnings Date

Mar 18, 2027

Ex-Dividend Date

―

PELL Bio-Med Technology Co Ltd as a current ratio of 4.31, with Debt / Equity ratio of 16.70%

Current Ratio

4.31

Quick Ratio

4.29

Debt to Market Cap

0.00

Net Debt to EBITDA

0.16

Interest Coverage Ratio

-228.53

In the past 12 months, PELL Bio-Med Technology Co Ltd has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

PELL Bio-Med Technology Co Ltd EV to EBITDA ratio is -107.43, with an EV/FCF ratio of -75.80.

EV to Sales

1645.71

EV to EBITDA

-107.43

EV to Free Cash Flow

-75.80

EV to Operating Cash Flow

-119.05

PELL Bio-Med Technology Co Ltd has TWD 2.27B in cash and marketable securities with TWD 231.52M in debt, giving a net cash position of TWD 2.04B billion.

Cash & Marketable Securities

TWD 2.27B

Total Debt

TWD 231.52M

Net Cash

TWD 2.04B

Net Cash Per Share

TWD 1.55

Tangible Book Value Per Share

TWD 2.14

Gross margin is -49.38%, with operating margin of -1719.94%, and net profit margin of -1559.49%.

Gross Margin

-49.38%

Operating Margin

-1719.94%

Pretax Margin

-1657.96%

Net Profit Margin

-1559.49%

EBITDA Margin

-1531.87%

EBIT Margin

-1713.08%

The average price target for PELL Bio-Med Technology Co Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

5.45%

EPS Growth Forecast

-17.06%